Filing Details

Accession Number:
0001179110-13-013257
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-08-16 17:36:17
Reporting Period:
2013-08-15
Filing Date:
2013-08-16
Accepted Time:
2013-08-16 17:36:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1145460 Alere Inc. ALR In Vitro & In Vivo Diagnostic Substances (2835) 043565120
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1383959 Dave Teitel 51 Sawyer Road, Suite 200
Waltham MA 02453
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-08-15 10,000 $21.38 14,506 No 4 M Direct
Common Stock Disposition 2013-08-15 10,000 $31.73 4,506 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2013-08-15 10,000 $0.00 10,000 $21.38
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-12-11 No 4 M Direct
Footnotes
  1. The transactions reported on this Form were made pursuant to a Rule 10b5-1 trading plan adopted in accordance with SEC Rule 10b5-1. Represents same day exercise and sale of expiring stock options.
  2. This price represents the average purchase price for 106 separate transactions reported on this line. The price of the transactions reported on this line range from $31.49 to $32.26. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or any stockholder of the issuer the full information regarding the number of shares and prices at which the transaction was effected.
  3. These options became exercisable in four equal annual installments beginning 12/11/2004.
  4. This derivative security does not have a price.
  5. Includes 377 shares acquired under the Alere Inc. Employee Stock Purchase Plan on June 30, 2013.